These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24675874)

  • 1. Structural and functional characterization of a complex between the acidic transactivation domain of EBNA2 and the Tfb1/p62 subunit of TFIIH.
    Chabot PR; Raiola L; Lussier-Price M; Morse T; Arseneault G; Archambault J; Omichinski JG
    PLoS Pathog; 2014 Mar; 10(3):e1004042. PubMed ID: 24675874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR structure of the complex between the Tfb1 subunit of TFIIH and the activation domain of VP16: structural similarities between VP16 and p53.
    Langlois C; Mas C; Di Lello P; Jenkins LM; Legault P; Omichinski JG
    J Am Chem Soc; 2008 Aug; 130(32):10596-604. PubMed ID: 18630911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53.
    Di Lello P; Jenkins LMM; Jones TN; Nguyen BD; Hara T; Yamaguchi H; Dikeakos JD; Appella E; Legault P; Omichinski JG
    Mol Cell; 2006 Jun; 22(6):731-740. PubMed ID: 16793543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
    Wang L; Grossman SR; Kieff E
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):430-5. PubMed ID: 10618435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR structure of the amino-terminal domain from the Tfb1 subunit of TFIIH and characterization of its phosphoinositide and VP16 binding sites.
    Di Lello P; Nguyen BD; Jones TN; Potempa K; Kobor MS; Legault P; Omichinski JG
    Biochemistry; 2005 May; 44(21):7678-86. PubMed ID: 15909982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.
    Ponnusamy R; Khatri R; Correia PB; Wood CD; Mancini EJ; Farrell PJ; West MJ
    PLoS Pathog; 2019 Jul; 15(7):e1007458. PubMed ID: 31283782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.
    Harter MR; Liu CD; Shen CL; Gonzalez-Hurtado E; Zhang ZM; Xu M; Martinez E; Peng CW; Song J
    PLoS Pathog; 2016 Feb; 12(2):e1005414. PubMed ID: 26845565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.
    Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW
    PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and TFIIEalpha share a common binding site on the Tfb1/p62 subunit of TFIIH.
    Di Lello P; Miller Jenkins LM; Mas C; Langlois C; Malitskaya E; Fradet-Turcotte A; Archambault J; Legault P; Omichinski JG
    Proc Natl Acad Sci U S A; 2008 Jan; 105(1):106-11. PubMed ID: 18160537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
    Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
    Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
    Gross H; Hennard C; Masouris I; Cassel C; Barth S; Stober-Grässer U; Mamiani A; Moritz B; Ostareck D; Ostareck-Lederer A; Neuenkirchen N; Fischer U; Deng W; Leonhardt H; Noessner E; Kremmer E; Grässer FA
    PLoS One; 2012; 7(8):e42106. PubMed ID: 22879910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
    J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional evidence that Rad4 competes with Rad2 for binding to the Tfb1 subunit of TFIIH in NER.
    Lafrance-Vanasse J; Arseneault G; Cappadocia L; Legault P; Omichinski JG
    Nucleic Acids Res; 2013 Feb; 41(4):2736-45. PubMed ID: 23295669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells.
    Beer S; Wange LE; Zhang X; Kuklik-Roos C; Enard W; Hammerschmidt W; Scialdone A; Kempkes B
    Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2200512119. PubMed ID: 35857872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes.
    Su C; Lu F; Soldan SS; Lamontagne RJ; Tang HY; Napoletani G; Farrell PJ; Tempera I; Kossenkov AV; Lieberman PM
    PLoS Pathog; 2021 Aug; 17(8):e1009834. PubMed ID: 34352044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional characterization of interactions involving the Tfb1 subunit of TFIIH and the NER factor Rad2.
    Lafrance-Vanasse J; Arseneault G; Cappadocia L; Chen HT; Legault P; Omichinski JG
    Nucleic Acids Res; 2012 Jul; 40(12):5739-50. PubMed ID: 22373916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional characterization of an atypical activation domain in erythroid Kruppel-like factor (EKLF).
    Mas C; Lussier-Price M; Soni S; Morse T; Arseneault G; Di Lello P; Lafrance-Vanasse J; Bieker JJ; Omichinski JG
    Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10484-9. PubMed ID: 21670263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.
    Peng R; Tan J; Ling PD
    J Virol; 2000 Nov; 74(21):9953-63. PubMed ID: 11024123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization of interactions between transactivation domain 1 of the p65 subunit of NF-κB and transcription regulatory factors.
    Lecoq L; Raiola L; Chabot PR; Cyr N; Arseneault G; Legault P; Omichinski JG
    Nucleic Acids Res; 2017 May; 45(9):5564-5576. PubMed ID: 28334776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.
    Zhao B; Zou J; Wang H; Johannsen E; Peng CW; Quackenbush J; Mar JC; Morton CC; Freedman ML; Blacklow SC; Aster JC; Bernstein BE; Kieff E
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14902-7. PubMed ID: 21746931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.